Explore

Trendline Trendline
Eli Lilly Showcases Weight Loss Drug Benefits at American Diabetes Association Meeting

Eli Lilly Showcases Weight Loss Drug Benefits at American Diabetes Association Meeting

Eli Lilly Showcases Weight Loss Drug Benefits at American Diabetes Association Meeting
Trendline Trendline
Eli Lilly Unveils Promising Obesity Therapy Results at ADA Conference

Eli Lilly Unveils Promising Obesity Therapy Results at ADA Conference

Eli Lilly Unveils Promising Obesity Therapy Results at ADA Conference
Trendline Trendline
Merck and Gilead Discontinue Phase 3 Study of Trodelvy and KEYTRUDA Combination

Merck and Gilead Discontinue Phase 3 Study of Trodelvy and KEYTRUDA Combination

Merck and Gilead Discontinue Phase 3 Study of Trodelvy and KEYTRUDA Combination
Trendline Trendline
Eli Lilly's Retatrutide Shows Promising Weight Loss Results in Obesity Treatment

Eli Lilly's Retatrutide Shows Promising Weight Loss Results in Obesity Treatment

Eli Lilly's Retatrutide Shows Promising Weight Loss Results in Obesity Treatment
Trendline Trendline
Kailera Therapeutics Prepares for Global Trials Following Record-Breaking IPO

Kailera Therapeutics Prepares for Global Trials Following Record-Breaking IPO

Kailera Therapeutics Prepares for Global Trials Following Record-Breaking IPO
Trendline Trendline
Eli Lilly's Retatrutide Achieves Significant Weight Loss in Obesity Treatment

Eli Lilly's Retatrutide Achieves Significant Weight Loss in Obesity Treatment

Eli Lilly's Retatrutide Achieves Significant Weight Loss in Obesity Treatment
Trendline Trendline
Kailera Therapeutics Advances Obesity Treatment with Promising Study Results

Kailera Therapeutics Advances Obesity Treatment with Promising Study Results

Kailera Therapeutics Advances Obesity Treatment with Promising Study Results
Trendline Trendline
Pfizer's Berobenatide Shows Promise in Obesity Market with New Data

Pfizer's Berobenatide Shows Promise in Obesity Market with New Data

Pfizer's Berobenatide Shows Promise in Obesity Market with New Data
Trendline Trendline
Eli Lilly's Weight Loss Drug Shows Promising Results for Menopausal Women

Eli Lilly's Weight Loss Drug Shows Promising Results for Menopausal Women

Eli Lilly's Weight Loss Drug Shows Promising Results for Menopausal Women
Trendline Trendline
Roche and Zealand Pharma's Amylin Analog Petrelintide Shows Moderate Weight Loss in Phase 2 Study

Roche and Zealand Pharma's Amylin Analog Petrelintide Shows Moderate Weight Loss in Phase 2 Study

Roche and Zealand Pharma's Amylin Analog Petrelintide Shows Moderate Weight Loss in Phase 2 Study
Rapid Read Rapid Read
Boston Pride Parade 2026 Celebrates 'Pride as Protest Since 1776'

Boston Pride Parade 2026 Celebrates 'Pride as Protest Since 1776'

The Boston Pride Parade for 2026 has adopted the theme 'Pride as Protest Since 1776,' emphasizing the historical struggle for LGBTQ+ rights in the context of the nation's founding. The event highlighted the ongoing fight for equality and recognition within the LGBTQ+ community, drawing parallels between the American Revolution and the modern-day quest for civil rights. The parade served as a platform to celebrate diversity and advocate for continued progress in LGBTQ+ rights, with participants and organizers underscoring the importance of protest in achieving social change.
AP News AP News
Just in time for Ozuna's first return visit with Pirates, Smith shows Braves found another strong DH

Just in time for Ozuna's first return visit with Pirates, Smith shows Braves found another strong DH

Dominic Smith is providing strong production as a veteran taking the lead role at designated hitter for the Atlanta Braves